30040 Federal Register / Vol. 75, No. 103 / Friday, May 28, 2010 / Notices 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Complementary and Alternative Medicine 

Special Emphasis Panel; Education Panel. 

Date: June 24–25, 2010. 

Time: 5:30 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications, 

Place: Hotel Monaco, 700 F Street, NW., 

Washington, DC 20001. 

Contact Person: Peter Kozel, PhD, 

Scientific Review Officer, NCCAM, 6707 

Democracy Boulevard, Suite 401, Bethesda, 

MD 20892–5475, 301–496–8004, 

kozelp@mail.nih.gov. 

Name of Committee: National Center for 

Complementary and Alternative Medicine 

Special Emphasis Panel; RFA AT–01–001 

‘‘Translational Tools For Clinical Studies of 

CAM Interventions’’. 

Date: June 28–29, 2010. 

Time: 7 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suites, 5151 

Pooks Hill Road, Bethesda, MD 20814. 

Contact Person: Ray Bramhall, PhD, 

Scientific Review Officer, National Center for 

Complementary and Alternative Medicine, 

6707 Democracy Blvd., Suite 401, Bethesda, 

MD 20892, 301–451–6570, 

bramhallr@mail.nih.gov. 

Name of Committee: National Center for 

Complementary and Alternative Medicine 

Special Emphasis Panel; PA–10–067 

‘‘Research Project Grant (Parent R01) 

Date: June 29, 2010. 

Time: 1 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suites, 5151 

Pooks Hill Road, Bethesda, MD 20814. 

Contact Person: Ray Bramhall, PhD, 

Scientific Review Officer, National Center for 

Complementary and Alternative Medicine, 

6707 Democracy Blvd., Suite 401, Bethesda, 

MD 20892, 301–451–6570, 

bramhallr@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.213, Research and Training 

in Complementary and Alternative Medicine, 

National Institutes of Health, HHS) 

Dated: May 21, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–12924 Filed 5–27–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; NIAID Science Education 

Awards. 

Date: June 23, 2010. 

Time: 11 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6700B 

Rockledge Drive, Bethesda, MD 20817. 

Contact Person: Nancy Lewis Ernst, PhD, 

Scientific Review Official, Scientific Review 

Program, Division of Extramural Activities, 

National Institutes of Health/NIAID, 6700B 

Rockledge Drive, MSC 7616, Bethesda, MD 

20892–7616, 301–451–7383, 

nancy.ernst@nih.gov. 

Name of Committee: Microbiology, 

Infectious Diseases and AIDS Initial Review 

Group; Acquired Immunodeficiency 

Syndrome Research Review Committee. 

Date: July 14, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Sujata Vijh, PhD, Scientific 

Review Officer, Scientific Review Program, 

Division of Extramural Activities, National 

Institutes of Health/NIAID, 6700B Rockledge 

Drive, MSC 7616, Bethesda, MD 20892–7616, 

301–594–0985, vijhs@niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: May 24, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–12938 Filed 5–27–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Research 

Resources; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Research Resources Special Emphasis Panel; 

Research on Integrity in Collaborative 

Research. 

Date: July 15, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Rockville, 1750 Rockville 

Pike, Roosevelt, Rockville, MD 20852. 

Contact Person: Barbara J. Nelson, PhD, 

Scientific Review Officer, Office of Review, 

NCRR, National Institutes of Health, 6701 

Democracy Blvd., 1 Democracy Plaza, Room 

1080, MSC 4874, Bethesda, MD 20892–4874, 

301–435–0806. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research; 93.371, Biomedical 

Technology; 93.389, Research Infrastructure; 

93.306, 93.333, 93.702, ARRA Related 

Construction Awards; National Institutes of 

Health, HHS) 

Dated: May 24, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–12941 Filed 5–27–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control 

Special Emphasis Panel (SEP): 

Member Conflict Review, Program 

Announcement (PA) 07–318, Initial 

Review 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 1:30 p.m.–3 p.m., July 28, 

2010 (Closed). 

Place: National Institute for Occupational 

Safety and Health (NIOSH), CDC, 1095 

Willowdale Road, Morgantown, West 

Virginia 26506, telephone: (304) 285–6143. 


jlentini on DSKJ8SOYB1PROD with NOTICES
Federal Register / Vol. 75, No. 103 / Friday, May 28, 2010 / Notices 30041 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c) (4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters to be Discussed: The meeting will 

include the initial review, discussion, and 

evaluation of ‘‘Member Conflict Review, PA 

07–318.’’ 

Contact Person for More Information: M. 

Chris Langub, PhD, Scientific Review 

Administrator, Office of Extramural 

Programs, National Institute for Occupational 

Safety and Health, CDC, 1600 Clifton Road, 

NE., Mailstop E74, Atlanta, Georgia 30333; 

Telephone: (404)498–2543. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: May 20, 2010. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–12829 Filed 5–27–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control 

Special Emphasis Panel (SEP): 

Effectiveness of Empiric Antiviral 

Treatment for Hospitalized Community 

Acquired Pneumonia during the 

Influenza Season, Funding Opportunity 

Announcement (FOA) IP10–007, Initial 

Review 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 12 p.m.–2 p.m., June 

15, 2010 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to 

the public in accordance with 

provisions set forth in Section 552b(c) 

(4) and (6), Title 5 U.S.C., and the 

Determination of the Director, 

Management Analysis and Services 

Office, CDC, pursuant to Public Law 92– 

463. 

Matters to be Discussed: The meeting 

will include the initial review, 

discussion, and evaluation of 

applications received in response to 

‘‘Effectiveness of Empiric Antiviral 

Treatment for Hospitalized Community 

Acquired Pneumonia during the 

Influenza Season, FOA IP10–007’’. 

Contact Person for More Information: 

Gregory Anderson, M.S., M.P.H., 

Scientific Review Officer, CDC, 1600 

Clifton Road, NE., Mailstop E60, 

Atlanta, GA 30333, Telephone: (404) 

498–2293. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both CDC 

and the Agency for Toxic Substances 

and Disease Registry. 

Dated: May 20, 2010. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–12827 Filed 5–27–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–1340–N] 

Medicare Program; Public Meeting in 

Calendar Year 2010 for New Clinical 

Laboratory Tests Payment 

Determinations 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), HHS. 

ACTION: Notice. 

SUMMARY: This notice announces a 

public meeting to receive comments and 

recommendations (including 

accompanying data on which 

recommendations are based) from the 

public on the appropriate basis for 

establishing payment amounts for a 

specified list of new Clinical Procedural 

Terminology (CPT) codes for clinical 

laboratory tests in calendar year (CY) 

2011. The meeting provides a forum for 

interested parties to make presentations 

and submit written comments on the 

new codes that will be included in 

Medicare’s Clinical Laboratory Fee 

Schedule for CY 2011, which will be 

effective on January 1, 2011. The 

development of the codes for clinical 

laboratory tests is largely performed by 

the CPT Editorial Panel and will not be 

further discussed at the meeting. 

DATES: Meeting Date: The public 

meeting is scheduled for Thursday, July 

22, 2010 from 9 a.m. to 2 p.m., Eastern 

Standard Time (E.S.T.). 

Deadline for Registration of 

Presenters: All presenters for the public 

meeting must register by July 16, 2010. 

Deadline for Submitting Requests for 

Special Accommodations: Requests for 

special accommodations must be 

received no later than 5 p.m., E.S.T. on 

July 16, 2010. 

Deadline for Submission of Written 

Comments: Interested parties may 

submit written comments on the 

proposed payment determinations by 

September 24, 2010, to the address 

specified in the ADDRESSES section of 

this notice. 

ADDRESSES: The public meeting will be 

held in the main auditorium of the 

central building of the Centers for 

Medicare & Medicaid Services (CMS), 

7500 Security Boulevard, Baltimore, 

Maryland 21244–1850. 

FOR FURTHER INFORMATION CONTACT: 

Glenn McGuirk, (410) 786–5723. 

SUPPLEMENTARY INFORMATION: 

I. Background 

Section 531(b) of the Medicare, 

Medicaid, and SCHIP Benefits 

Improvement and Protection Act of 

2000 (BIPA) (Pub. L. 106–554) requires 

the Secretary to establish procedures for 

coding and payment determinations for 

new clinical diagnostic laboratory tests 

under Part B of title XVIII of the Social 

Security Act (the Act) that permit public 

consultation in a manner consistent 

with the procedures established for 

implementing coding modifications for 

International Classification of Diseases 

(ICD–9–CM). The procedures and public 

meeting announced in this notice for 

new clinical laboratory tests are in 

accordance with the procedures 

published on November 23, 2001 in the 

Federal Register (66 FR 58743) to 

implement section 531(b) of BIPA. 

Section 942(b) of the Medicare 

Prescription Drug, Improvement, and 

Modernization Act of 2003 (MMA) (Pub. 

L. 108–173) added section 1833(h)(8) of 

the Act. Section 1833(h)(8)(A) of the Act 

states that such new tests are any 

clinical diagnostic laboratory tests with 

respect to which a new or substantially 

revised Healthcare Common Procedures 

Coding System (HCPCS) code is 

assigned on or after January 1, 2005 

(hereinafter referred to as, ‘‘new test’’ or 

‘‘new clinical laboratory test’’). Section 

1833(h)(8)(B) of the Act sets forth the 

methods for determining payment bases 

for new tests. Pertinent to this notice, 

section 1833(h)(8)(B)(i) and (ii) of the 

Act requires the Secretary to make 

available to the public a list that 

includes new tests for which 

establishment of a payment amount is 

being considered for a year and, on the 

same day that the list is made available, 

to publish in the Federal Register a 

notice of a meeting to receive comments 


jlentini on DSKJ8SOYB1PROD with NOTICES